Oncotelic Therapeutics, Inc. (OTLC) stock
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Oncotelic Therapeutics's profit margin for the twelve months ending Dec 31, 2023 was -11290.1%. For fiscal 2023 it was -11290.1%, against -545.9% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -11290.1% | −10744.3 |
| FY2020 | Dec 31, 2020 | -545.9% | +8166.8 |
| FY2013 | Dec 31, 2013 | -8712.6% | −3533.8 |
| FY2012 | Dec 31, 2012 | -5178.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 155.3% | – |
| Q3 FY2023 | Sep 30, 2023 | 164.7% | – |
| Q2 FY2020 | Jun 30, 2020 | 41.6% | – |
| Q1 FY2020 | Mar 31, 2020 | -1366.5% | – |
See a number that looks wrong?